Minimum Investment
₹129,000
Price Range
₹41 to ₹43
Lot Size
3000 shares
Issue Size
₹12 Cr
About the Company
Goldline Pharmaceuticals is engaged in the business of marketing pharmaceutical products under the brand name “Goldline.”
Bookbuilding IPO
IPO Objectives
- Prepayment or repayment of all or a portion of certain outstanding borrowings availed by our company
- General corporate purposes
Important Dates
| Bid/Offer Opens On | 12-05-2026 |
| Bid/Offer Closes On | 14-05-2026 |
| Finalisation of Basis of Allotment | 15-05-2026 |
| Initiation of Refunds | 18-05-2026 |
| Credit of Shares to Demat | 18-05-2026 |
| IPO Listing Date | 19-05-2026 |
IPO Subscription Status
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 540,000 | 97,317,000 | 180.22x |
| NII | 390,000 | 648,333,000 | 1,662.39x |
| NII ( >10 lakh) | 260,000 | 518,874,000 | 1,995.67x |
| NII ( <10 lakh) | 130,000 | 129,459,000 | 995.84x |
| Retail | 900,000 | 793,038,000 | 881.15x |
| Total | 1,830,000 | 1,538,688,000 | 840.81x |
Grey Market Premium (GMP)
—
Registrar
Bigshare Services Pvt.Ltd.
Lead Managers
- Cumulative Capital Pvt.Ltd.
Company Promoters
- Amol Laxmikant Mujumdar and Swapan Premprakash Khandelwal are the company promoters.
